Concert Pharmaceuticals, Inc. Operating Income 2014-2022 | CNCE

Concert Pharmaceuticals, Inc. operating income from 2014 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Concert Pharmaceuticals, Inc. Annual Operating Income
(Millions of US $)
2021 $-78
2020 $-73
2019 $-79
2018 $-56
2017 $93
2016 $-51
2015 $25
2014 $-31
2013 $-4
2012 $-19
2011 $-11
Concert Pharmaceuticals, Inc. Quarterly Operating Income
(Millions of US $)
2022-09-30 $-30
2022-06-30 $-26
2022-03-31 $-36
2021-12-31 $-33
2021-09-30 $-27
2021-06-30 $6
2021-03-31 $-24
2020-12-31 $-22
2020-09-30 $-19
2020-06-30 $-13
2020-03-31 $-19
2019-12-31 $-21
2019-09-30 $-18
2019-06-30 $-19
2019-03-31 $-20
2018-12-31 $-20
2018-09-30 $-17
2018-06-30 $-14
2018-03-31 $-4
2017-12-31 $-13
2017-09-30 $132
2017-06-30 $-13
2017-03-31 $-13
2016-12-31 $-12
2016-09-30 $-11
2016-06-30 $-14
2016-03-31 $-14
2015-12-31 $1
2015-09-30 $-9
2015-06-30 $42
2015-03-31 $-9
2014-12-31 $-9
2014-09-30 $-8
2014-06-30 $-8
2014-03-31 $-7
2013-12-31 $-6
2013-09-30 $-7
2013-06-30 $9
2013-03-31 $-1